Reducing Relapse for People with Schizophrenia in Jakarta, Indonesia: Developing a culturally-relevant, evidence-based Family Intervention
减少印度尼西亚雅加达精神分裂症患者的复发:制定与文化相关、循证的家庭干预措施
基本信息
- 批准号:MR/T003987/1
- 负责人:
- 金额:$ 19.09万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2021
- 资助国家:英国
- 起止时间:2021 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Mental illnesses comprise the single largest source of health-related economic burden worldwide. Schizophrenia is among the most disabling conditions in these low-resource settings and 90% of those who need treatment do not receive it. Consequently, much of the burden of care is transferred to families who have few resources to support them in caring for their loved one. Often, carers lack knowledge and expertise about how to manage and having caring responsibilities significantly affects their own quality of life.In high-resource settings family interventions (FIp) are provided as a 'talking therapy' for relatives and carers. These types of interventions focus on helping families to cope with illness, learn how to communicate, solve problems and set goals for treatment. Families also find these interventions supportive and reassuring which helps with their own coping and emotions. These interventions are known to be highly effective but they may not translate directly from one culture to another because there are differences in the way people view mental illnesses, how they see and communicate with each other and how treatment is organised. The aim of this study is to see whether we will be able to tailor an intervention we know is effective in the UK to the needs of people living in Indonesia. To do this, we will ask people in groups what they think of the intervention, about their experiences with getting help and how schizophrenia has affected their lives. We will ask them how they would like to receive the intervention in the future, what aspects are important to include, what type of therapist they would prefer and how and when they would like to receive the intervention. We will then gather a panel of experts to make a final decision about the intervention and ask them what kind of resources they think would help to train people. We will develop a manual to help people who deliver the intervention to deliver these interventions well and we will prepare teaching resources so that in the future, they can teach others to deliver the intervention.The final part of this work is to train people to deliver the intervention in a primary care setting. A large trial of this intervention would use lots of valuable resources to complete and would not be a good use of resources if we don't know that we can complete the trial. For example, we might not be able to recruit people so before we get to that stage we will do a small trial and see if all the pieces work together, we can recruit everyone we need and collect all the information we need. We also need to make sure that healthcare professionals delivering the intervention can do this with the manual as it is described. We will then need to check with the people who receive the intervention that they like it, whether we could change parts to make it better and whether people delivering it also like it. At the same time, we will be thinking about how this will work in primary care, we will be having conversations with the right people who will use or be affected by our new intervention and we will tell them about what we are doing.
精神疾病是全世界与健康相关的经济负担的最大单一来源。精神分裂症是这些低资源环境中最令人残疾的疾病之一,90%需要治疗的人没有得到治疗。因此,大部分护理负担都转移到了几乎没有资源支持他们照顾所爱之人的家庭。通常情况下,照顾者缺乏如何管理的知识和专业知识,照顾责任会严重影响他们自己的生活质量。在资源丰富的环境中,家庭干预(FIP)被提供给亲属和照顾者作为“谈话疗法”。这些类型的干预措施侧重于帮助家庭应对疾病、学习如何沟通、解决问题和制定治疗目标。家庭也发现这些干预是支持性的和令人放心的,这有助于他们自己的应对和情绪。众所周知,这些干预措施非常有效,但它们可能不会直接从一种文化转化为另一种文化,因为人们看待精神疾病的方式、他们如何看待和交流彼此以及如何组织治疗存在差异。这项研究的目的是看看我们是否能够量身定做一种我们知道在英国有效的干预措施,以满足生活在印度尼西亚的人们的需求。为了做到这一点,我们将分组询问人们对干预的看法,他们获得帮助的经历,以及精神分裂症如何影响他们的生活。我们会询问他们将来希望如何接受干预,包括哪些方面是重要的,他们更喜欢什么类型的治疗师,以及他们希望如何和何时接受干预。然后,我们将召集一个专家小组,就干预措施做出最终决定,并询问他们认为什么样的资源将有助于培训人员。我们将编写一本手册,帮助提供干预措施的人很好地提供这些干预措施,我们还将准备教学资源,以便他们将来可以教其他人提供干预措施。这项工作的最后一部分是培训人们在初级保健环境中提供干预措施。这种干预的大规模试验将使用大量宝贵的资源来完成,如果我们不知道我们能否完成试验,就不是对资源的良好利用。例如,我们可能无法招聘人员,所以在达到这个阶段之前,我们将进行一个小规模的试验,看看是否所有的部分都起作用了,我们可以招募我们需要的每个人,并收集我们需要的所有信息。我们还需要确保提供干预的医疗保健专业人员可以按照手册的说明进行干预。然后,我们需要向接受干预的人核实他们是否喜欢它,我们是否可以更换部件以使其更好,以及提供干预的人是否也喜欢它。与此同时,我们将考虑这将如何在初级保健中发挥作用,我们将与使用我们新干预措施或受到我们新干预措施影响的合适人员进行对话,我们将告诉他们我们正在做什么。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Culturally Adapted Family Intervention for People With Schizophrenia in Indonesia (FUSION): A Development and Feasibility Study Protocol
印度尼西亚精神分裂症患者文化适应家庭干预(FUSION):开发和可行性研究方案
- DOI:10.21203/rs.3.rs-994129/v1
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Renwick L
- 通讯作者:Renwick L
Culturally adapting family interventions for schizophrenia in Indonesia: A Development and Consensus Study
印度尼西亚精神分裂症的文化适应家庭干预措施:一项发展和共识研究
- DOI:
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Laoise Renwick
- 通讯作者:Laoise Renwick
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laoise Jean Renwick其他文献
Laoise Jean Renwick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Innovative ligands for nuclear receptors to eradicate cancer relapse
核受体的创新配体可根除癌症复发
- 批准号:
EP/Y030818/1 - 财政年份:2024
- 资助金额:
$ 19.09万 - 项目类别:
Research Grant
MONALISA: A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis
MONALISA:一项 SIOPEN 实用临床试验,通过液体活检监测神经母细胞瘤复发 敏感性分析
- 批准号:
10103126 - 财政年份:2024
- 资助金额:
$ 19.09万 - 项目类别:
EU-Funded
A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis (MONALISA)
SIOPEN 通过液体活检敏感性分析 (MONALISA) 监测神经母细胞瘤复发的实用临床试验
- 批准号:
10110442 - 财政年份:2024
- 资助金额:
$ 19.09万 - 项目类别:
EU-Funded
Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and Co-Occurring PTSD: A Randomized Clinical Trial
认知处理疗法与酒精使用障碍和并发 PTSD 复发预防的整合:一项随机临床试验
- 批准号:
10934633 - 财政年份:2023
- 资助金额:
$ 19.09万 - 项目类别:
Modeling cue-triggered relapse to cocaine use in rats
模拟提示触发大鼠可卡因吸毒复发
- 批准号:
479766 - 财政年份:2023
- 资助金额:
$ 19.09万 - 项目类别:
Operating Grants
Phenotypic and Functional Characterization of Relapse-Fated Cells Present at Diagnosis in AML leading to improved therapeutic targeting and monitoring
AML 诊断时存在的复发性细胞的表型和功能特征可改善治疗靶向和监测
- 批准号:
489132 - 财政年份:2023
- 资助金额:
$ 19.09万 - 项目类别:
Operating Grants
Identifying multi-omic signatures of opioid use and relapse
识别阿片类药物使用和复发的多组学特征
- 批准号:
10724297 - 财政年份:2023
- 资助金额:
$ 19.09万 - 项目类别:
A clinical trial of adaptive treatment for early smoking cessation relapse
早期戒烟复发适应性治疗的临床试验
- 批准号:
10752773 - 财政年份:2023
- 资助金额:
$ 19.09万 - 项目类别:
Deep Sequencing of Relapse and Refractory Hodgkin Lymphoma Genomes: A Study of Tumor Biology and Evolution
复发和难治性霍奇金淋巴瘤基因组的深度测序:肿瘤生物学和进化的研究
- 批准号:
10351582 - 财政年份:2023
- 资助金额:
$ 19.09万 - 项目类别:
Targeting CD83 to reduce leukemia relapse and GVHD after allogeneic hematopoietic cell transplantation
靶向CD83减少同种异体造血细胞移植后白血病复发和GVHD
- 批准号:
10573570 - 财政年份:2023
- 资助金额:
$ 19.09万 - 项目类别:














{{item.name}}会员




